Vascepa and Kenalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vascepa and Kenalog. Common interactions include gallbladder enlargement among females and renal injury among males.

The phase IV clinical study analyzes what interactions people who take Vascepa and Kenalog have. It is created by eHealthMe based on reports of 18 people who take Vascepa and Kenalog from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

18 people who take Vascepa and Kenalog together, and have interactions are studied.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 4,592 Vascepa users for its effectiveness, alternative drugs and more.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 9,370 Kenalog users for its effectiveness, alternative drugs and more.

Number of Vascepa and Kenalog reports submitted per year:

Common Vascepa and Kenalog drug interactions by gender *:

female:

Gallbladder enlargement
Gastroenteritis
Injection site pain
Flank pain
Chronic gastritis
Sinusitis
Acute sinusitis
Appendicitis
Arthralgia
Diverticulitis

male:

Renal injury
Chronic kidney disease
Groin infection
Renal failure
Gastrooesophageal reflux disease
Leukocytosis
Necrotising fasciitis
Renal tubular necrosis
Sepsis
Urinary tract infection

Common Vascepa and Kenalog drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Leukocytosis
Necrotising fasciitis
Renal injury
Renal tubular necrosis
Sepsis
Urinary tract infection
Cellulitis
Chronic kidney disease
Gastrooesophageal reflux disease
Groin infection

50-59:

n/a

60+:

Gallbladder enlargement
Gastroenteritis
Intra-abdominal haemorrhage
Iron deficiency anaemia
Orthostatic hypotension
Pain in extremity
Torticollis
Dermal cyst
Fall
Urticaria

Common conditions people have *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 88.89%
Type 2 Diabetes: 15 people, 83.33%
Stress And Anxiety: 15 people, 83.33%
Constipation: 14 people, 77.78%
High Blood Pressure: 14 people, 77.78%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 13 people, 72.22%
Asthma: 13 people, 72.22%
Dizziness: 13 people, 72.22%
Essential Tremor: 13 people, 72.22%
Fibromyalgia (a long-term condition which causes pain all over the body): 13 people, 72.22%

* Approximation only. Some reports may have incomplete information.

Do you take Vascepa and Kenalog?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.